Yakir Rottenberg

MD
Positions: Senior expert of the Oncology Department of the Hadassah University Hospital.
Experience: 16 years

---

Areas of Expertise and Treatment

Oncology:

---

Holds a license for prescribing medical cannabis issued by the Israeli Ministry of Health

EDUCATION

• 2003 — Graduated from the Faculty of Medicine of the Hebrew University of Jerusalem (Israel).
• 2009 — Obtained a second academic degree in social hygiene and healthcare organization from the Hebrew University of Jerusalem.
• 2014 — Completed a course on biomedical innovations at the Hebrew University of Jerusalem.
• 2019 — Completed a special course on the use of biotechnologies in personalized medicine and digital means and narcotic medicines at the Hebrew University of Jerusalem.

CLINICAL EXPERIENCE

• 2004–2009 — Specialization in oncology at the Hadassah University Hospital (Jerusalem, Israel).
• 2009–2012 — Specialization in geriatric rehabilitation at the Hadassah University Hospital.

AWARDS AND HONORS

2019 — the prestigious grant of the National Cancer Association for research in nasal chemotherapy of cerebrovascular diseases.

INVENTIONS AND PATENTS

• The doctor is widely known as the inventor of the CureSign© device used to monitor the patient’s response to cancer therapy.
• The author of several patents in narcotic substance use for the rehabilitation of patients with various forms of cancer.

PROFESSIONAL MEMBERSHIPS:

• The Israeli Association of Oncology
• The International Association of Oncology (IAO)

LANGUAGE SKILLS

English, Hebrew